Skip to Main Content

++

KEY POINTS

++

KEY POINTS

  1. Congenital heart diseases that decrease cardiopulmonary reserve include intracardiac shunting, hypoxemia from inadequate pulmonary blood flow or intracardiac shunting, congestive failure from volume or pressure overload, vascular obstructive disease from excessive pulmonary blood flow, various kinds of stenosis, and occasional coronary ischemia.

  2. Many of the determinants of shunting (its magnitude and direction) may change considerably during anesthesia and operative manipulations.

  3. There are simple shunts, bidirectional shunts, and occasionally complex shunts. The key for anesthesia providers is to understand the effects of vasodilators, cardiac depressants, and surgical manipulation on these various shunts.

  4. “Bubble discipline” is an important concept for patients with congenital heart disease.

  5. Chronic hypoxia leads to polycythemia, which in turn leads to dramatic increases in blood viscosity.

  6. The anesthesia provider should understand the hemodynamic consequences of pulmonary vascular hypertrophy, the end stage of which is Eisenmenger syndrome.

  7. Even though a child with congenital heart disease may not have frank failure, cardiac reserve may be dramatically decreased, especially if episodes of prolonged congestive failure have been part of the patient’s history and have resulted in cardiomegaly or ventricular hypertrophy.

  8. “Transitional circulation” keeps neonates with severe life-threatening congenital heart disease alive. In this context, therapy with prostaglandin E1 infusion should be understood, especially the possibility of side effects such as apnea and major vasodilation.

  9. The functional capacities of the immature heart should be of particular interest to anesthesia providers. The immature noncompliant ventricle is extraordinarily sensitive to increases in volume and is considerably restricted in its ability to respond by increasing stroke volume. The Starling curve plateau in neonates is reached at left ventricular end-diastolic pressures of 4 mm Hg. Therefore, cardiac compliance values in neonates do not correspond to values for adult patients.

  10. Adult arterial pressures, especially during bypass, do not apply to neonates and infants.

  11. The procedures for weaning from bypass and using deep hypothermic circulatory arrest, low-flow hypothermic bypass, or antegrade cerebral perfusion are important and should be reviewed in detail.

  12. The anesthesia provider should understand the hemodynamic consequences and purpose of various pulmonary artery banding procedures and transcatheter management of congenital lesions.

  13. Intravenous anesthetics, including high-dose opioids, ketamine, or etomidate may provide increased margins of safety in some infants with congenital heart disease.

  14. Intramuscular ketamine 3 to 5 mg/kg is reasonably well tolerated, even in sick children with cyanotic congenital heart disease.

  15. Inhaled nitric oxide is a clinically useful and efficacious selective pulmonary vasodilator for many, but not all, patients with congenital heart disease.

++

INTRODUCTION

++

The goal of anesthetic management during the surgical treatment of patients with congenital heart disease (CHD) is maintenance of circulatory homeostasis despite the destabilizing events accompanying the therapeutic procedures. Anesthesia for management of CHD is complicated by the diversity of lesions and the variety of therapeutic approaches. Congenital cardiac defects vary widely in severity, anatomic combinations, and pathophysiologic conditions. Complex cardiovascular pathophysiologic conditions change dynamically with time, organ development, and therapeutic interventions. Therefore, ...

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.